Drugs News and Research

RSS

Study examines self-reported use of bath salts among high school seniors in the U.S.

Recent years have seen an unprecedented growth in number and availability of new synthetic psychoactive drugs in the US and worldwide. In 2014, 101 new psychoactive drugs were identified, worldwide. Such drugs are often sold as "legal" highs or "research chemicals" over the internet or in head shops. Among these new drugs, "bath salts" appear to be one of the more commonly used in the US.

16 Jul 2015

Two chemical compounds effectively inhibit growth of brain cancer cells and breast tumors

Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumors, opening the way for potential new drugs to be developed.

16 Jul 2015

Oral PAH treatments stave off clinical decline

Oral treatments for pulmonary arterial hypertension reduce patients’ risk of clinical worsening but have little effect on survival, say the authors of a meta-analysis.

15 Jul 2015

Women with low levels of anti-stress hormone at increased risk of getting breast cancer

A new study from Lund University in Sweden shows that women with low levels of an anti-stress hormone have an increased risk of getting breast cancer. The study is the first of its kind on humans and confirms previous similar observations from animal experiments.

15 Jul 2015

Study highlights how KLF15 protein affects availability of nutrients in the body

Case Western Reserve researchers already demonstrated that a single protein plays a pivotal role in the use of nutrients by major organs that allow for the burning of fat during exercise or regulating the heart's contractile and electrical activity. Now they have found a new benefit of Kruppel-like Factor 15 (KLF15) — keeping the body in metabolic balance.

15 Jul 2015

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

An Indiana University Melvin and Bren Simon Cancer Center researcher played a role in the recent Food and Drug Administration approval of a drug to treat people exposed to potentially lethal doses of radiation.

15 Jul 2015

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

Among patients with diabetic kidney disease and hyperkalemia (elevated potassium levels in the blood), a potentially life-threatening condition, those who received the new drug patiromer, twice daily for four weeks, had significant decreases in potassium levels which lasted through one year, according to a study in the July 14 issue of JAMA.

15 Jul 2015

Agilent and BTI collaborate to address a critical need in biopharmaceutical industry

The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.

15 Jul 2015

New study finds that intellectual pursuits can buffer the brain's reward system against drug dependence

Challenging the idea that addiction is hardwired in the brain, a new UC Berkeley study of mice suggests that even a short time spent in a stimulating learning environment can rewire the brain's reward system and buffer it against drug dependence.

15 Jul 2015

Hyperbaric oxygen treatment effective for fibromyalgia

Fibromyalgia is almost impossible to diagnose. The chronic pain syndrome strikes an estimated 1 in 70 Americans, most of them women. The disorder is often triggered by head trauma, a neurological infection, or severe emotional stress, and is characterized by symptoms such as musculoskeletal pain, fatigue, memory loss and mood swings. Fibromyalgia is often mistaken for other culprits and most patients suffer months, even years, of unrelenting pain before being properly diagnosed. And once diagnosed, patients enjoy little respite because few therapies have been found to be effective in assuaging its symptoms.

15 Jul 2015

Benzodiazepine drugs ineffective for PTSD and trauma treatment

Benzodiazepine drugs are widely used in patients with posttraumatic stress disorder (PTSD), but available evidence suggests that they are not effective--and may even be harmful, concludes a systematic review and meta-analysis in the July Journal of Psychiatric Practice.

15 Jul 2015

Most patients with depression excluded from antidepressant trials, study finds

More than 80 percent of people with depression in the general population aren't eligible for clinical trials of antidepressant drugs, according to a study in the Journal of Psychiatric Practice.

15 Jul 2015

Study shows possibility of using embryonic stem cells to repair damaged lung tissue

Collectively, such diseases of the airways as emphysema, bronchitis, asthma and cystic fibrosis are the second leading cause of death worldwide. More than 35 million Americans alone suffer from chronic respiratory disease. Weizmann Institute scientists have now proposed a new direction that could, in the future, lead to the development of a method for alleviating some of their suffering.

15 Jul 2015

Lilly Diabetes releases Android version of Glucagon Mobile App to support diabetes caregivers

Lilly Diabetes has released an Android version of its mobile application designed for caregivers and healthcare providers who support people with diabetes. Through an injection tutorial and emergency instructions, the App can help people practice the injection steps ahead of time, which may help them feel better prepared to assist.

15 Jul 2015

ForeverGreen Worldwide earns BSCG's anti-doping certification for PowerStrips

ForeverGreen Worldwide Corporation, a leading direct marketing company and provider of health-centered products, today announced the company has received an anti-doping certification from the Banned Substances Control Group for PowerStrips, indicating the product is free of banned substances.

14 Jul 2015

Paul G. Allen Family Foundation announces ADI grants for Alzheimer's disease research

The Paul G. Allen Family Foundation announced today the award of Allen Distinguished Investigator (ADI) grants to five teams of researchers with projects that will open new and innovative avenues of research in Alzheimer's disease by uncovering its elusive biological roots.

14 Jul 2015

Isis Pharmaceuticals receives $2.15 million milestone payment to advance ISIS-SMN Rx study in children with SMA

Isis Pharmaceuticals, Inc. announced today that it has earned a $2.15 million milestone payment from Biogen related to advancing the ongoing pivotal Phase 3 study (CHERISH) evaluating ISIS-SMN Rx in children with spinal muscular atrophy (SMA).

14 Jul 2015

New analysis explores importance of medical imaging in drug development, understanding pathological physiology

The use of small animal models in basic and preclinical research is now an integral part of developing and testing new pharmaceutical drugs prior to commercialisation.

14 Jul 2015

Single molecule appears to be central regulator driving cancer metastasis

Cancer is a disease of cell growth, but most tumors only become lethal once they metastasize or spread from their first location to sites throughout the body. For the first time, researchers at Thomas Jefferson University in Philadelphia report a single molecule that appears to be the central regulator driving metastasis in prostate cancer.

14 Jul 2015

New study identifies potential antidepressant medications with few side effects

A new study by researchers at University of Maryland School of Medicine has identified promising compounds that could successfully treat depression in less than 24 hours while minimizing side effects. Although they have not yet been tested in people, the compounds could offer significant advantages over current antidepressant medications.

14 Jul 2015

Drugs News and Research

Study examines self-reported use of bath salts among high school seniors in the U.S.

Two chemical compounds effectively inhibit growth of brain cancer cells and breast tumors

Oral PAH treatments stave off clinical decline

Women with low levels of anti-stress hormone at increased risk of getting breast cancer

Study highlights how KLF15 protein affects availability of nutrients in the body

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

Agilent and BTI collaborate to address a critical need in biopharmaceutical industry

New study finds that intellectual pursuits can buffer the brain's reward system against drug dependence

Hyperbaric oxygen treatment effective for fibromyalgia

Benzodiazepine drugs ineffective for PTSD and trauma treatment

Most patients with depression excluded from antidepressant trials, study finds

Study shows possibility of using embryonic stem cells to repair damaged lung tissue

Lilly Diabetes releases Android version of Glucagon Mobile App to support diabetes caregivers

ForeverGreen Worldwide earns BSCG's anti-doping certification for PowerStrips

Paul G. Allen Family Foundation announces ADI grants for Alzheimer's disease research

Isis Pharmaceuticals receives $2.15 million milestone payment to advance ISIS-SMN Rx study in children with SMA

New analysis explores importance of medical imaging in drug development, understanding pathological physiology

Single molecule appears to be central regulator driving cancer metastasis

New study identifies potential antidepressant medications with few side effects

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News